semaglutide weight loss liver transplant recipients Use of weight-loss pharmacotherapy in patients with cirrhosis and in ACG 2023 Annual Meeting

Lab Work and Provider Analysis As part of our program, patients will undergo detailed lab work to assess their overall health and ensure the safe and effective use of Semaglutide / Tirzepatide

Have Information Ready: When you call for help, try to have some information ready

GLP-1s support healthspan rather than reverse aging

Baseline Demographics and Medication Profiles A total of 125 youth were included (median age 14.83 years), with 113 on metformin and 12 on GLP-1RA therapy

32 There are low rates of serious and severe infections and of malignancies in those receiving FAE, similar to or lower than with methotrexate, cyclosporine, or biologics